한글목차

자성 나노입자는 그 특수한 특성으로 인해 다양한 분야에서 폭넓게 응용되고 있습니다. 특히 자성 나노입자는 마그네토펙션, 광열요법, 광역학 치료, 표적 약물전달, 자기 온열요법 등 암 치료에 많이 활용되고 있습니다.

폐수 산업에서 자성 나노입자에 대한 수요 증가는 미국과 중국의 자성 나노입자 시장에 성장 기회를 가져올 것으로 예상됩니다.

미국 및 중국의 자성 나노입자 시장은 바이오메디컬 및 헬스케어 부문의 확대에 의해 주도될 전망입니다. 전처리 키트 공정에서 자성 나노입자 기술의 사용 증가는 미국 자성 나노입자 시장을 주도하고 있습니다.

세계 자성 나노입자 시장을 조사했으며, 시장 정의와 개요, 시장 성장에 영향을 미치는 요인과 시장 기회 분석, 시장 규모 추이 및 예측, 각종 부문별·지역별 분석, 경쟁 환경, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 시장 개요

제2장 시장 역학

• 개요
• 성장 촉진요인
  • 미국의 바이오메디컬 및 헬스케어 부문 확대
  • 중국의 바이오메디컬 및 헬스케어 부문 확대
  • 전처리 키트의 자성 나노입자 기술 사용 증가
• 성장 억제요인
  • 중국의 자성 나노입자 재료 가격 변동
  • 미국의 자성 나노입자 재료 가격 변동
  • 자성 나노입자 재료의 독성과 생체적합성
• 기회
  • 수처리에서의 자성 나노입자 사용 증가
• 동향
  • 자성을 이용해 표적 병원균을 분리·농축할 수 있는 자성 나노입자의 코어 기술
  • 자성 나노입자를 이용한 패혈증 나노 진단 기술(MNPS)

제3장 자성 나노입자 관능기와 사이즈 정성 분석

• 기능 그룹별
• 사이즈별
• 바이오 진단에 사용되는 자기 비즈 기반 방법 : 개요

제4장 경쟁 상황

• 경쟁 분석
• 시장 점유율 분석
• 주요 성장 전략(바이오 진단 최종사용자)
• 경쟁 벤치마킹
• 개발 건수에서의 리더 기업
• 주요 전개·성장 전략
• 주요 기업 재무 데이터

제5장 기업 개요

• QIAGEN NV
• BIONEER CORPORATION
• T2 BIOSYSTEMS, INC.
• THERMO FISHER SCIENTIFIC INC.
• HOFFMANN-LA ROCHE LTD
• CREATIVE BIOGENE
• MAGGENOME TECHNOLOGIES PVT. LTD.
• DAAN GENE CO., LTD.
• MAGBIO GENOMICS INC.
• BECKMAN COULTER INC.(DANAHER CORPORATION)
• XI'AN TIANLONG SCIENCE AND TECHNOLOGY CO., LTD
• GUANGZHOU DONGSHENG BIOTECH CO., LTD
• GENEAID BIOTECH LTD.
• TIANGEN BIOTECH(BEIJING) CO., LTD.
• WUXI NEST BIOTECHNOLOGY CO., LTD

영문목차

Market Overview

Magnetic nanoparticles define as the use of tiny particles that possess magnetic properties are typically ranging from 1 to 500 nanometres in size. Magnetic Nanoparticles is receptor immobilized magnetic nanoparticles bind specifically to bacteria and viruses. It is a core technology that can separate and concentrate target pathogens through magnetism. After directly synthesizing magnetic nanoparticles, self-coating is performed to prevent aggregation and then, various functional groups possessed are fixed to realize a concentrating effect. These nanoparticles are often composed of magnetic materials such as iron, cobalt, or nickel, or their alloys. They exhibit unique characteristics such as magnetic behavior at the nanoscale, which can be manipulated and controlled for various applications including wastewater treatment, electronics, healthcare sector, biomedical, energy and other application. Magnetic nanoparticles have a wide range of uses in different fields due to their special properties. Most notably, magnetic nanoparticles are frequently employed in cancer treatment methods like magnetofection, photothermal therapy, photodynamic therapy, targeted drug delivery, and magnetic hyperthermia.

However, the fluctuations in the prices of magnetic nanoparticles materials and toxicity and biocompatibility of magnetic nanoparticles materials will likely restrain market growth. On the other hand, to rise in demand for magnetic nanoparticles from wastewater industry will create growth opportunities for the US and China Magnetic Nanoparticles market.

Market Segmentation

The functional group of magnetic particles has been majorly classified into -COOH, -NH2, -SiO2, -Tosyl , and -Streptavidin.

The size range of magnetic particles has been majorly classified into 100, 200, 300, and 500 nm. The size of magnetic particles can greatly impact their magnetic behavior, surface area, stability, and interactions with other molecules or systems.

Regional Analysis

The US and China Magnetic Nanoparticles market is expected to be driven by increasing expansion of biomedical and healthcare sector in US and China. The Increase usage of magnetic nanoparticles technology in process of pretreatment kits are driving the US Magnetic Nanoparticles market.

Major Players

Qiagen N. V., Bioneer Corporation, T2 Biosystems Inc., Thermo Fisher Scientific Inc., Hoffmann-La Roche Ltd., Creative Biogene, Baker Coulters Inc. (Danaher Corporation), MagBio Genomics Inc., DaAn Gene Co., Ltd, and MagGenome Technologies Pvt. Ltd among others are the major companies in the Magnetic Nanoparticles Market.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1 DEFINITION
• 1.2 SCOPE OF THE STUDY
• 1.3 RESEARCH OBJECTIVE
• 1.4 MARKET STRUCTURE
• 1.5 LIST OF ASSUMPTIONS

2 MARKET DYNAMICS

• 2.1 OVERVIEW
• 2.2 DRIVERS
  • 2.2.1 EXPANSION OF BIOMEDICAL AND HEALTHCARE SECTOR IN US
  • 2.2.2 EXPANSION OF BIOMEDICAL AND HEALTHCARE SECTOR IN CHINA
  • 2.2.3 INCREASE USAGE OF MAGNETIC NANOPARTICLES TECHNOLOGY IN PRETREATMENT KITS
• 2.3 RESTRAINTS
  • 2.3.1 FLUCTUATIONS IN THE PRICES OF MAGNETIC NANOPARTICLES MATERIALS IN CHINA
  • 2.3.2 FLUCTUATIONS IN THE PRICES OF MAGNETIC NANOPARTICLES MATERIALS IN US
  • 2.3.3 TOXICITY AND BIOCOMPATIBILITY OF MAGNETIC NANOPARTICLES MATERIALS
• 2.4 OPPORTUNITIES
  • 2.4.1 INCREASING USE OF MAGNETIC NANOPARTICLES FOR WATER TREATMENT
• 2.5 TRENDS
  • 2.5.1 CORE TECHNOLOGY OF MAGNETIC NANOPARTICLES THAT CAN SEPARATE AND CONCENTRATE TARGET PATHOGENS THROUGH MAGNETISM
  • 2.5.2 NANODIAGNOSTIC TECHNOLOGIES FOR SEPSIS USING MAGNETIC NANOPARTICLES (MNPS)

3 QUALITATIVE ANALYSIS ON FUNCTIONAL GROUP AND SIZE FOR MAGNETIC NANOPARTICLES

• 3.1 BY FUNCTIONAL GROUP
• 3.2 BY SIZE
• 3.3 OVERVIEW OF MAGNETIC BEAD-BASED METHOD EMPLOYED IN BIO-DIAGNOSTICS

4 COMPETITIVE LANDSCAPE

• 4.1 INTRODUCTION
• 4.2 COMPETITIVE ANALYSIS
• 4.3 MARKET SHARE ANALYSIS
• 4.4 MAJOR GROWTH STRATEGY IN THE MAGNETIC NANOPARTICES MARKET (BIO-DIAGNOSTIC END USERS)
• 4.5 COMPETITIVE BENCHMARKING
• 4.6 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN MAGNETIC NANOPARTICLES MARKET
• 4.7 KEY DEVELOPMENTS & GROWTH STRATEGIES
  • 4.7.1 PRODUCT LAUNCH/ PRODUCT DEVELOPMENT
  • 4.7.2 PARTNERSHIP/COLLABORATION
• 4.8 MAJOR PLAYER FINANCIAL*
  • 4.8.1 SALES, OPERATING INCOME, R&D EXPENDITURE 2022*

5 COMPANY PROFILES

• 5.1 QIAGEN NV
  • 5.1.1 COMPANY OVERVIEW
  • 5.1.2 FINANCIAL OVERVIEW
  • 5.1.3 PRODUCTS OFFERED
  • 5.1.4 KEY DEVELOPMENTS
  • 5.1.5 SWOT ANALYSIS
  • 5.1.6 KEY STRATEGIES
• 5.2 BIONEER CORPORATION
  • 5.2.1 COMPANY OVERVIEW
  • 5.2.2 FINANCIAL OVERVIEW
  • 5.2.3 PRODUCTS OFFERED
  • 5.2.4 KEY DEVELOPMENTS
  • 5.2.5 SWOT ANALYSIS
  • 5.2.6 KEY STRATEGIES
• 5.3 T2 BIOSYSTEMS, INC.
  • 5.3.1 COMPANY OVERVIEW
  • 5.3.2 FINANCIAL OVERVIEW
  • 5.3.3 PRODUCTS OFFERED
  • 5.3.4 KEY DEVELOPMENTS
  • 5.3.5 SWOT ANALYSIS
  • 5.3.6 KEY STRATEGIES
• 5.4 THERMO FISHER SCIENTIFIC INC.
  • 5.4.1 COMPANY OVERVIEW
  • 5.4.2 FINANCIAL OVERVIEW
  • 5.4.3 PRODUCTS OFFERED
  • 5.4.4 KEY DEVELOPMENTS
  • 5.4.5 SWOT ANALYSIS
  • 5.4.6 KEY STRATEGIES
• 5.5 HOFFMANN-LA ROCHE LTD
  • 5.5.1 FINANCIAL OVERVIEW
  • 5.5.2 PRODUCTS OFFERED
  • 5.5.3 KEY DEVELOPMENTS
  • 5.5.4 SWOT ANALYSIS
  • 5.5.5 KEY STRATEGIES
• 5.6 CREATIVE BIOGENE
  • 5.6.1 COMPANY OVERVIEW
  • 5.6.2 FINANCIAL OVERVIEW
  • 5.6.3 PRODUCTS OFFERED
  • 5.6.4 KEY DEVELOPMENTS
  • 5.6.5 SWOT ANALYSIS
  • 5.6.6 KEY STRATEGIES
• 5.7 MAGGENOME TECHNOLOGIES PVT. LTD.
  • 5.7.1 COMPANY OVERVIEW
  • 5.7.2 FINANCIAL OVERVIEW
  • 5.7.3 PRODUCTS OFFERED
  • 5.7.4 KEY DEVELOPMENTS
  • 5.7.5 SWOT ANALYSIS
  • 5.7.6 KEY STRATEGIES
• 5.8 DAAN GENE CO., LTD.
  • 5.8.1 COMPANY OVERVIEW
  • 5.8.2 FINANCIAL OVERVIEW
  • 5.8.3 PRODUCTS OFFERED
  • 5.8.4 KEY DEVELOPMENTS
  • 5.8.5 SWOT ANALYSIS
  • 5.8.6 KEY STRATEGIES
• 5.9 MAGBIO GENOMICS INC.
  • 5.9.1 COMPANY OVERVIEW
  • 5.9.2 FINANCIAL OVERVIEW
  • 5.9.3 PRODUCTS OFFERED
  • 5.9.4 KEY DEVELOPMENTS
  • 5.9.5 SWOT ANALYSIS
  • 5.9.6 KEY STRATEGIES
• 5.10 BECKMAN COULTER INC. (DANAHER CORPORATION)
• 5.10. COMPANY OVERVIEW
• 5.10. FINANCIAL OVERVIEW
• 5.10. PRODUCTS OFFERED

5.10.4KEY DEVELOPMENTS

5.10.5SWOT ANALYSIS

5.10.6KEY STRATEGIES

• 5.11 XI'AN TIANLONG SCIENCE AND TECHNOLOGY CO., LTD

5.11.1COMPANY OVERVIEW

5.11.2FINANCIAL OVERVIEW

5.11.3PRODUCTS OFFERED

5.11.4KEY DEVELOPMENTS

5.11.5SWOT ANALYSIS

5.11.6KEY STRATEGIES

• 5.12 GUANGZHOU DONGSHENG BIOTECH CO., LTD

5.12.1COMPANY OVERVIEW

5.12.2FINANCIAL OVERVIEW

5.12.3PRODUCTS OFFERED

5.12.4KEY DEVELOPMENTS

5.12.5SWOT ANALYSIS

5.12.6KEY STRATEGIES

• 5.13 GENEAID BIOTECH LTD.

5.13.1COMPANY OVERVIEW

5.13.2FINANCIAL OVERVIEW

5.13.3PRODUCTS OFFERED

5.13.4KEY DEVELOPMENTS

5.13.5SWOT ANALYSIS

5.13.6KEY STRATEGIES

• 5.14 TIANGEN BIOTECH(BEIJING)CO., LTD.98

5.14.1COMPANY OVERVIEW

5.14.2FINANCIAL OVERVIEW

5.14.3PRODUCTS OFFERED

5.14.4KEY DEVELOPMENTS

5.14.5SWOT ANALYSIS

5.14.6KEY STRATEGIES

• 5.15 WUXI NEST BIOTECHNOLOGY CO., LTD

5.15.1COMPANY OVERVIEW

5.15.2FINANCIAL OVERVIEW

5.15.3PRODUCTS OFFERED

5.15.4KEY DEVELOPMENTS

5.15.5SWOT ANALYSIS

5.15.6KEY STRATEGIES